These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 26597741)

  • 41. Soluble endoglin for the prediction of preeclampsia in a high risk cohort.
    Maynard SE; Moore Simas TA; Bur L; Crawford SL; Solitro MJ; Meyer BA
    Hypertens Pregnancy; 2010; 29(3):330-41. PubMed ID: 20670156
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Second-trimester uterine artery Doppler, PlGF, sFlt-1, sEndoglin, and lipid-related markers for predicting preeclampsia in a high-risk population.
    Diguisto C; Le Gouge A; Piver E; Giraudeau B; Perrotin F
    Prenat Diagn; 2013 Nov; 33(11):1070-4. PubMed ID: 23847040
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A prospective study of screening for hypertensive disorders of pregnancy at 11-13 weeks in a Scandinavian population.
    Skråstad RB; Hov GG; Blaas HG; Romundstad PR; Salvesen KÅ
    Acta Obstet Gynecol Scand; 2014 Dec; 93(12):1238-47. PubMed ID: 25146367
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Human chorionic gonadotropin, angiogenic factors, and preeclampsia risk: a nested case-control study.
    Asvold BO; Eskild A; Vatten LJ
    Acta Obstet Gynecol Scand; 2014 May; 93(5):454-62. PubMed ID: 24575980
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Examining the correlation between placental and serum placenta growth factor in preeclampsia.
    Weed S; Bastek JA; Anton L; Elovitz MA; Parry S; Srinivas SK
    Am J Obstet Gynecol; 2012 Aug; 207(2):140.e1-6. PubMed ID: 22704767
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Prospective study of placental angiogenic factors and maternal vascular function before and after preeclampsia and gestational hypertension.
    Noori M; Donald AE; Angelakopoulou A; Hingorani AD; Williams DJ
    Circulation; 2010 Aug; 122(5):478-87. PubMed ID: 20644016
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Added value of angiogenic factors for the prediction of early and late preeclampsia in the first trimester of pregnancy.
    Crovetto F; Figueras F; Triunfo S; Crispi F; Rodriguez-Sureda V; Peguero A; Dominguez C; Gratacos E
    Fetal Diagn Ther; 2014; 35(4):258-66. PubMed ID: 24714555
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prediction of preeclampsia with maternal mid-trimester placental growth factor, activin A, fibronectin and uterine artery Doppler velocimetry.
    Madazli R; Kuseyrioglu B; Uzun H; Uludag S; Ocak V
    Int J Gynaecol Obstet; 2005 Jun; 89(3):251-7. PubMed ID: 15919391
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Placental growth factor (PlGF) is a surrogate marker in preeclamptic hypertension.
    Teixeira PG; Cabral AC; Andrade SP; Reis ZS; da Cruz LP; Pereira JB; Martins BO; Rezende CA
    Hypertens Pregnancy; 2008; 27(1):65-73. PubMed ID: 18293205
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Second- and third-trimester serum levels of placental proteins in preeclampsia and small-for-gestational age pregnancies.
    Bersinger NA; Ødegård RA
    Acta Obstet Gynecol Scand; 2004 Jan; 83(1):37-45. PubMed ID: 14678084
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Automated assays for sVEGF R1 and PlGF as an aid in the diagnosis of preterm preeclampsia: a prospective clinical study.
    Sunderji S; Gaziano E; Wothe D; Rogers LC; Sibai B; Karumanchi SA; Hodges-Savola C
    Am J Obstet Gynecol; 2010 Jan; 202(1):40.e1-7. PubMed ID: 19762001
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The importance of repeated measurements of the sFlt-1/PlGF ratio for the prediction of preeclampsia and intrauterine growth restriction.
    Schoofs K; Grittner U; Engels T; Pape J; Denk B; Henrich W; Verlohren S
    J Perinat Med; 2014 Jan; 42(1):61-8. PubMed ID: 23929878
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Evaluation of a new and automated electrochemiluminescence immunoassay for plasma sFlt-1 and PlGF levels in women with preeclampsia.
    Ohkuchi A; Hirashima C; Suzuki H; Takahashi K; Yoshida M; Matsubara S; Suzuki M
    Hypertens Res; 2010 May; 33(5):422-7. PubMed ID: 20150910
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Circulating angiogenic factors and placental abruption.
    Signore C; Mills JL; Qian C; Yu K; Lam C; Epstein FH; Karumanchi SA; Levine RJ
    Obstet Gynecol; 2006 Aug; 108(2):338-44. PubMed ID: 16880304
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combination of uterine artery Doppler velocimetry and maternal serum placental growth factor estimation in predicting occurrence of pre-eclampsia in early second trimester pregnancy: a prospective cohort study.
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Eur J Obstet Gynecol Reprod Biol; 2012 Apr; 161(2):144-51. PubMed ID: 22280827
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia: a prospective multicenter study.
    Chappell LC; Duckworth S; Seed PT; Griffin M; Myers J; Mackillop L; Simpson N; Waugh J; Anumba D; Kenny LC; Redman CW; Shennan AH
    Circulation; 2013 Nov; 128(19):2121-31. PubMed ID: 24190934
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin A in singleton and multiple-gestation pregnancies.
    Boucoiran I; Thissier-Levy S; Wu Y; Wei SQ; Luo ZC; Delvin E; Fraser WD; Audibert F;
    Am J Perinatol; 2013 Aug; 30(7):607-12. PubMed ID: 23208763
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Role of maternal plasma levels of placental growth factor for the prediction of maternal complications in preeclampsia according to the gestational age at onset.
    Meler E; Scazzocchio E; Peguero A; Triunfo S; Gratacos E; Figueras F
    Prenat Diagn; 2014 Jul; 34(7):706-10. PubMed ID: 24752879
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
    Caritis S; Sibai B; Hauth J; Lindheimer MD; Klebanoff M; Thom E; VanDorsten P; Landon M; Paul R; Miodovnik M; Meis P; Thurnau G
    N Engl J Med; 1998 Mar; 338(11):701-5. PubMed ID: 9494145
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.